These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer. Rancourt C; Bergeron C; Lane D; Garon G; Piché A Cytotherapy; 2003; 5(6):509-22. PubMed ID: 14660047 [TBL] [Abstract][Full Text] [Related]
23. [Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro]. Kong H; Huang ZH; Li Q; Yang LC; Yu JL; Li Z Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):907-10. PubMed ID: 18583225 [TBL] [Abstract][Full Text] [Related]
24. TK-GFP fusion gene virus vectors as tools for studying the features of HSV-TK/ganciclovir cancer gene therapy in vivo. Pasanen T; Hakkarainen T; Timonen P; Parkkinen J; Tenhunen A; Loimas S; Wahlfors J Int J Mol Med; 2003 Oct; 12(4):525-31. PubMed ID: 12964030 [TBL] [Abstract][Full Text] [Related]
26. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model. Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830 [TBL] [Abstract][Full Text] [Related]
27. Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration. van der Eb MM; Cramer SJ; Vergouwe Y; Schagen FH; van Krieken JH; van der Eb AJ; Borel Rinkes IH; van de Velde CJ; Hoeben RC Gene Ther; 1998 Apr; 5(4):451-8. PubMed ID: 9614568 [TBL] [Abstract][Full Text] [Related]
28. Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer. Kijima T; Osaki T; Nishino K; Kumagai T; Funakoshi T; Goto H; Tachibana I; Tanio Y; Kishimoto T Cancer Res; 1999 Oct; 59(19):4906-11. PubMed ID: 10519403 [TBL] [Abstract][Full Text] [Related]
29. Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models. Mizuno M; Ryuke Y; Yoshida J Cancer Gene Ther; 2002 Oct; 9(10):825-9. PubMed ID: 12224023 [TBL] [Abstract][Full Text] [Related]
30. In vivo gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration. Tong XW; Block A; Chen SH; Contant CF; Agoulnik I; Blankenburg K; Kaufman RH; Woo SL; Kieback DG Gynecol Oncol; 1996 May; 61(2):175-9. PubMed ID: 8626129 [TBL] [Abstract][Full Text] [Related]
31. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir. Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025 [TBL] [Abstract][Full Text] [Related]
32. GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the Tat8-TK as a late gene in a pancreatic tumour model. Cascante A; Abate-Daga D; Garcia-Rodríguez L; González JR; Alemany R; Fillat C Gene Ther; 2007 Oct; 14(20):1471-80. PubMed ID: 17713568 [TBL] [Abstract][Full Text] [Related]
33. ATRA enhances bystander effect of suicide gene therapy in the treatment of prostate cancer. Chen W; Yan C; Hou J; Pu J; Ouyang J; Wen D Urol Oncol; 2008; 26(4):397-405. PubMed ID: 18367126 [TBL] [Abstract][Full Text] [Related]
34. Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk. Morris JC; Wildner O Mol Ther; 2000 Jan; 1(1):56-62. PubMed ID: 10933912 [TBL] [Abstract][Full Text] [Related]
35. [Gene therapy using recombinant adenovirus carrying herpes simplex-thymidine kinase gene to treat mouse B 16 melanoma in vivo]. Xu RE; Ying BB; Zhao SY; Li CB Shi Yan Sheng Wu Xue Bao; 1997 Sep; 30(3):261-71. PubMed ID: 11039021 [TBL] [Abstract][Full Text] [Related]
36. Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity. Odaka M; Sterman DH; Wiewrodt R; Zhang Y; Kiefer M; Amin KM; Gao GP; Wilson JM; Barsoum J; Kaiser LR; Albelda SM Cancer Res; 2001 Aug; 61(16):6201-12. PubMed ID: 11507073 [TBL] [Abstract][Full Text] [Related]
37. Immune-dependent distant bystander effect after adenovirus-mediated suicide gene transfer in a rat model of liver colorectal metastasis. Agard C; Ligeza C; Dupas B; Izembart A; El Kouri C; Moullier P; Ferry N Cancer Gene Ther; 2001 Feb; 8(2):128-36. PubMed ID: 11263528 [TBL] [Abstract][Full Text] [Related]
38. [Killing effect of adenovirus vector-mediated herpes simplex virus thymidine kinase gene recombinant construct on various cancer cells]. Zhou JF; Chen G; Lu YP; Wang SX; Ma D Ai Zheng; 2003 Dec; 22(12):1264-7. PubMed ID: 14693048 [TBL] [Abstract][Full Text] [Related]
39. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity. Wildner O; Morris JC Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625 [TBL] [Abstract][Full Text] [Related]
40. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]